000 01708 a2200481 4500
005 20250513194826.0
264 0 _c19991130
008 199911s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6690777
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSoubeyran, P
245 0 0 _aEvolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
_h[electronic resource]
260 _bBritish journal of cancer
_cNov 1999
300 _a860-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBase Sequence
650 0 4 _aChromosomes, Human, Pair 14
650 0 4 _aChromosomes, Human, Pair 18
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Heavy Chains
_xgenetics
650 0 4 _aLymphoma, Follicular
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aMolecular Sequence Data
650 0 4 _aNeoplastic Cells, Circulating
_xmetabolism
650 0 4 _aProspective Studies
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xgenetics
650 0 4 _aRNA, Neoplasm
_xbiosynthesis
650 0 4 _aSurvival Analysis
650 0 4 _aTranslocation, Genetic
700 1 _aHostein, I
700 1 _aDebled, M
700 1 _aEghbali, H
700 1 _aSoubeyran, I
700 1 _aBonichon, F
700 1 _aAstier-Gin, T
700 1 _aHoerni, B
773 0 _tBritish journal of cancer
_gvol. 81
_gno. 5
_gp. 860-9
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6690777
_zAvailable from publisher's website
999 _c10512334
_d10512334